Ml. Kireeva et al., ADHESION OF HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS TO THE IMMEDIATE-EARLY GENE-PRODUCT CYR61 IS MEDIATED THROUGH INTEGRIN ALPHA(V)BETA(3), The Journal of biological chemistry, 273(5), 1998, pp. 3090-3096
Cyr61 is a member of a family of growth factor-inducible immediate-ear
ly gene products thought to act cooperatively with the activities of g
rowth factors, Upon synthesis, Cyr61 is secreted and is predominantly
incorporated into the extracellular matrix, Recently, we demonstrated
that Cyr61 promotes cell adhesion and migration and augments growth fa
ctor-induced DNA synthesis (Kireeva, M, L., Mo, F.-E,, Yang, G, P., an
d Lau, L, F. (1996) Mol, Cell. Biol. 16, 1326-1334), In the present st
udy, we investigated possible candidate receptor(s) on human umbilical
vein endothelial cells (HUVECs) mediating adhesion to Cyr61. Under bo
th serum-containing and serum-free conditions, adhesion of HUVECs to C
yr61 was dose-dependent, saturable, and abolished by affinity-purified
anti-Cyr61 antibodies, Cell adhesion to Cyr61 was divalent cation-dep
endent and specifically inhibited by the peptide RGDS and LM609, a mon
oclonal antibody against integrin alpha(v) beta(3) Furthermore, purifi
ed alpha(v) beta(3) bound directly to an affinity matrix of Cyr61-coup
led Sepharose 4B, and this interaction was specifically blocked by ant
i-Cyr61 antibodies, Additionally, in a solid phase binding assay, solu
ble Cyr61 bound to immobilized gp, in a dose-dependent manner, and hal
f-saturation binding occurred at approximately 5 nM Cyr61, As expected
, the interaction of Cyr61 with immobilized alpha(v) beta(3) was block
ed by RGDS and LM609. In sum, these results identified Cyr61 as a nove
l ligand for alpha(v) beta(3) and indicate that the adhesion of HUVECs
to Cyr61 is mediated through interaction with this integrin, The poss
ibility that integrin alpha(v) eta(3) functions as a signaling recepto
r for Cyr61 accounts for most if not all activities that can be ascrib
ed to Cyr61 to date and suggests a mechanism of action discussed herei
n.